
itself into a global medical innovation hub stems first from its IP protection system, which is fully aligned with international rules and provides full-chain protection for innovative drugs and medi
nbsp; 责任编辑:雪花 文章内容举报
sp; 转自:证券时报人民财讯4月20日电,华纺股份(600448)4月20日披露年报,2025年实现营业收入29.4亿元,同比增长0.2%;归母净利润亏损2.61亿元。
ion from a major drug maker to a strong innovator in biopharmaceuticals.Delivering a speech at the 30th Hong Kong Medical Forum on Saturday, Hong Kong Financial Secretary Paul Chan Mo-po highlighted t
当前文章:http://4l2y.cenqiaota.cn/kae/nirvng.doc
发布时间:21:20:20
推荐阅读